The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of colon adenocarcinoma in situ in polyp with subsequent colon cancer: A population-based retrospective study.
 
Shuai Wang
No Relationships to Disclose
 
Apoorva Jayarangaiah
No Relationships to Disclose
 
Anahat Kaur
No Relationships to Disclose
 
Tarek N. Elrafei
No Relationships to Disclose
 
Lewis Steinberg
No Relationships to Disclose
 
Abhishek Kumar
Stock and Other Ownership Interests - Abbvie; Acadia Pharmaceuticals; ACADIA Pharmaceuticals; ADMA Biologics; Agenus; Agenus; Agenus; AIkido Pharma; Albireo Pharma; Amazon; Amazon; Amgen; Amgen; Amgen; AstraZeneca; AstraZeneca; AVEO; BeyondSpring Pharmaceuticals; BeyondSpring Pharmaceuticals; Bio-Path Holdings; Bio-Path Holdings, Inc; BioTelemetry; Blueprint Medicines; Blueprint Medicines; Bristol-Myers Squibb; Cara Therapeutics; Cara Therapeutics; Cardiff Oncology; Celgene; ChemBio Diagnostic Systems; Contrafect; crispr therapeutics; CryoLife; CVS Health; Editas Medicine; Editas Medicine; Five Prime Therapeutics; Five Prime Therapeutics; Geron; Globus Medical; Globus Medical; Google; IDEXX Laboratories; IDEXX Laboratories; Immunomedics; Immunomedics; Iovance Biotherapeutics; Iovance Biotherapeutics; Johnson & Johnson/Janssen; Kronos; Lilly; Livongo; Medtronic; Northwest Biotherapeutics; Northwest Biotherapeutics; Novavax; Ontrak; Pfizer; Poseida Therapeutics; Precision Biosciences; Precision Biosciences; PTC Therapeutics; PTC Therapeutics; Regeneron; Renalytix AI PLC; Sierra Oncology; SOC Telemed; SPDR S and P Biotech ETF; Spectrum Pharmaceuticals; Surgalign; Teladoc; Trovagene; Uniqure; VBI Vaccines; Vericel; Vertex; Vertex; Viatris; Viking Therapeutics; Viking Therapeutics